Skip to main content
Livermore
Livermore
ZHEN

Fennec Pharmaceuticals Inc.

FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Fennec Pharmaceuticals Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+11 vs. Q4 2022
Shares held
13.0M
+572.0K (+4.6%) vs. Q4 2022
Total value
$108.5M
−$11.1M (−9.2%) vs. Q4 2022
New holders
17
20 more added
Sold out
6
7 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 54 institutions
Q1 2021: 53 institutionsQ2 2021: 39 institutionsQ3 2021: 32 institutionsQ4 2021: 30 institutionsQ1 2022: 28 institutionsQ2 2022: 28 institutionsQ3 2022: 31 institutionsQ4 2022: 43 institutionsQ1 2023: 54 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 56 institutionsQ1 2024: 65 institutionsQ2 2024: 64 institutionsQ3 2024: 63 institutionsQ4 2024: 64 institutionsQ1 2025: 68 institutionsQ2 2025: 78 institutionsQ3 2025: 84 institutionsQ4 2025: 96 institutionsQ1 2026: 90 institutionsQ2 2026: 105 institutions
Value heldQ1 2023: $108.5M
Q1 2021: $89.3MQ2 2021: $88.0MQ3 2021: $109.7MQ4 2021: $49.9MQ1 2022: $64.1MQ2 2022: $63.2MQ3 2022: $92.1MQ4 2022: $119.5MQ1 2023: $108.5MQ2 2023: $124.5MQ3 2023: $107.6MQ4 2023: $168.4MQ1 2024: $161.1MQ2 2024: $87.7MQ3 2024: $74.6MQ4 2024: $101.4MQ1 2025: $81.6MQ2 2025: $112.9MQ3 2025: $129.8MQ4 2025: $119.6MQ1 2026: $99.6MQ2 2026: $175.1M
Institutions holding FENC and their total value by quarter
QuarterHoldersValue
Q2 2026105$175.1M
Q1 202690$99.6M
Q4 202596$119.6M
Q3 202584$129.8M
Q2 202578$112.9M
Q1 202568$81.6M
Q4 202464$101.4M
Q3 202463$74.6M
Q2 202464$87.7M
Q1 202465$161.1M
Q4 202356$168.4M
Q3 202355$107.6M
Q2 202356$124.5M
Q1 202354$108.5M
Q4 202243$119.5M
Q3 202231$92.1M
Q2 202228$63.2M
Q1 202228$64.1M
Q4 202130$49.9M
Q3 202132$109.7M
Q2 202139$88.0M
Q1 202153$89.3M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q4 2022.

Institutions holding FENC in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC112$9320.00%00.0%Unchanged
JPMorgan Chase & Co70$1.00K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA170$1.41K0.00%00.0%Unchanged
Wells Fargo & Company306$2.55K0.00%+306New
Royal Bank of Canada424$4.00K0.00%+133+45.7%Added
Tucker Asset Management LLC500$4.16K0.00%+500New
UBS Group AG705$5.87K0.00%+641+1,001.6%Added
State of Wyoming804$6.69K0.00%+804New
Advisor Group Holdings, Inc.3,060$25.5K0.00%−832−21.4%Reduced
Point72 Middle East FZE3,087$25.7K0.00%+3,087New
Point72 Asset Management, L.P.3,100$25.8K0.00%+3,100New
Tower Research Capital LLC (TRC)3,118$26.0K0.00%+26+0.8%Added
Bank of America Corp6,735$56.0K0.00%+4,535+206.1%Added
Barclays PLC9,697$80.7K0.00%+437+4.7%Added
Boothbay Fund Management, LLC10,818$90.0K0.00%+10,818New
Cubist Systematic Strategies, LLC11,304$94.0K0.00%+11,304New
LMR Partners LLP11,402$94.9K0.00%+11,402New
Trellus Management Company, LLC11,861$98.7K0.16%+11,861New
Jump Financial, LLC14,220$118.3K0.00%−6,771−32.3%Reduced
Marshall Wace, LLP15,066$125.3K0.00%+15,066New
Man Group plc–$139.6K0.00%––
Citigroup Inc18,590$151.1K0.00%+1,742+10.3%Added
Geode Capital Management, LLC19,507$162.3K0.00%00.0%Unchanged
Janney Montgomery Scott LLC20,000$166.0K0.00%+20,000New
Squarepoint Ops LLC20,393$169.7K0.00%+20,393New
Goldman Sachs Group Inc20,751$172.6K0.00%−234−1.1%Reduced
Toronto Dominion Bank25,400$204.0K0.00%+25,400New
Two Sigma Advisers, LP34,200$284.5K0.00%−20,800−37.8%Reduced
Bridgeway Capital Management, LLC34,200$284.5K0.01%00.0%Unchanged
Citadel Advisors LLC35,270$293.4K0.00%+7,216+25.7%Added
Qube Research & Technologies Ltd40,195$334.4K0.00%+22,923+132.7%Added
Hartford Financial Management Inc.41,348$344.0K0.09%+1,500+3.8%Added
Worth Venture Partners, LLC45,438$378.0K0.19%+45,438New
AWM Investment Company, Inc.47,600$396.0K0.05%+47,600New
BlackRock Inc.51,638$429.6K0.00%+1,094+2.2%Added
HRT Financial LP54,635$454.0K0.01%+54,635New
Morgan Stanley58,173$484.0K0.00%+12,797+28.2%Added
Two Sigma Investments, LP60,370$502.3K0.00%−27,301−31.1%Reduced
Jane Street Group, LLC88,240$734.2K0.00%+62,374+241.1%Added
Apis Capital Advisors, LLC90,000$748.8K0.80%+32,000+55.2%Added
1492 Capital Management LLC94,839$789.1K0.49%−310.0%Reduced
CIBC World Markets Inc.114,931$956.0K0.00%+15,568+15.7%Added
Tamarack Advisers, LP149,200$1.24M0.95%−63,800−30.0%Reduced
Susquehanna International Group, LLP161,320$1.34M0.00%+53,707+49.9%Added
AIGH Capital Management LLC162,154$1.35M0.50%+162,154New
Millennium Management LLC189,998$1.58M0.00%+62,709+49.3%Added
Gendell Jeffrey L252,286$2.10M0.20%+99,216+64.8%Added
683 Capital Management, LLC300,000$2.50M0.22%00.0%Unchanged
Harbert Fund Advisors, Inc.466,869$3.88M2.77%+149,920+47.3%Added
Avoro Capital Advisors LLC1,200,000$9.98M0.15%00.0%Unchanged
DG Capital Management, LLC1,250,096$10.4M5.89%+228,144+22.3%Added
Solas Capital Management, LLC1,284,543$10.7M5.71%+32,155+2.6%Added
Sonic GP LLC2,407,357$20.0M15.30%00.0%Unchanged
Southpoint Capital Advisors LP4,077,214$33.9M0.77%00.0%Unchanged
Opaleye Management Inc.0$00.00%−272,200−100.0%Sold out
EAM Investors, LLC0$00.00%−176,452−100.0%Sold out
Tamar Securities, LLC0$00.00%−53,475−100.0%Sold out
Ancora Advisors, LLC0$00.00%−12,245−100.0%Sold out
NewEdge Wealth, LLC0$00.00%−10,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,921−100.0%Sold out